Attached files

file filename
8-K - 8-K - RITE AID CORPv381807_8k.htm
Exhibit 99.1
 

Press Release

For Further Information Contact:

 

INVESTORS: MEDIA:
Matt Schroeder Susan Henderson
(717) 214-8867 (717) 730-7766

or investor@riteaid.com

 

FOR IMMEDIATE RELEASE

 

RITE AID REPORTS NET INCOME OF $41.4 MILLION AND ADJUSTED EBITDA

OF $282.6 MILLION FOR FIRST QUARTER FISCAL 2015

 

·First Quarter Net Income of $41.4 Million and Net Income per Diluted Share of $0.04, Compared to Prior Year’s First Quarter Net Income of $89.7 Million and Net Income per Diluted Share of $0.09

 

·First Quarter Adjusted EBITDA of $282.6 Million Compared to Adjusted EBITDA of $344.8 Million in Prior First Quarter

 

·Rite Aid Confirms Outlook for Fiscal 2015

 

CAMP HILL, Pa. (June 19, 2014) - Rite Aid Corporation (NYSE: RAD) today reported operating results for its fiscal first quarter ended May 31, 2014. The company reported revenues of $6.5 billion, net income of $41.4 million or $0.04 per diluted share, and Adjusted EBITDA of $282.6 million, or 4.4 percent of revenues.

 

“In the first quarter, we delivered a strong store operating performance, highlighted by increases in same-store sales and same-store prescription count,” said Rite Aid Chairman and CEO John Standley. “As we work through managing the higher-than-expected drug costs and reimbursement rate pressure that affected our financial results for the quarter, we remain focused on executing our strategy to expand our health care offering and transform Rite Aid into a growing retail health care company.”

 

 

 

 

 

 

-MORE-

  

 

 
 

 

Rite Aid FY 2015 Q1 Press Release - page 2

 

First Quarter Summary

 

Revenues for the quarter were $6.5 billion versus revenues of $6.3 billion in the prior year’s first quarter. Revenues increased 2.7 percent primarily as a result of an increase in pharmacy same store sales.

 

Same store sales for the quarter increased 3.1 percent over the prior year. Front-end same store sales were flat compared to the prior-year period while pharmacy same store sales increased 4.6 percent. Pharmacy sales included an approximate 143 basis point negative impact from new generic introductions. The number of prescriptions filled in same stores increased 2.3 percent over the prior year period. Prescription sales accounted for 68.4 percent of total drugstore sales, and third party prescription revenue was 97.4 percent of pharmacy sales.

 

Net income was $41.4 million or $0.04 per diluted share compared to last year’s first quarter net income of $89.7 million or $0.09 per diluted share. The decline in net income resulted primarily from a decrease in Adjusted EBITDA and higher income tax expense, partially offset by lower interest expense and a lower LIFO charge.

 

Adjusted EBITDA (which is reconciled to net income on the attached table) was $282.6 million or 4.4 percent of revenues for the first quarter compared to $344.8 million or 5.5 percent of revenues for the like period last year. The decrease in Adjusted EBITDA was driven by a reduction in pharmacy gross profit due to lower reimbursement rates that were not offset with reductions in generic costs, as well as higher salary and payroll related expenses.

 

In the first quarter, the company relocated 3 stores, remodeled 105 stores and expanded 1 store, bringing the total number of wellness stores chainwide to 1,325. The company also acquired 1 store and closed 7 stores, resulting in a total store count of 4,581 at the end of the first quarter.

 

Rite Aid Confirms Fiscal 2015 Guidance

 

Rite Aid has confirmed its fiscal 2015 guidance, which was updated on June 5, 2014. Sales are expected to be between $26.0 billion and $26.5 billion and same store sales to range from an increase of 2.50 percent to an increase of 4.50 percent over fiscal 2014. Adjusted EBITDA (which is reconciled to net income on the attached table) guidance is expected to be between $1.275 billion and $1.350 billion and net income is expected to be between $298.0 million and $408.0 million or income per diluted share of $0.30 to $0.40. Capital expenditures are expected to be approximately $525 million.

 

-More-

 

 
 

Rite Aid FY 2015 Q1 Press Release - page 3

 

Conference Call Broadcast

 

Rite Aid will hold an analyst call at 8:30 a.m. Eastern Time today with remarks by Rite Aid's management team. The call will be simulcast via the internet and can be accessed through the websites www.riteaid.com in the conference call section of investor information and www.StreetEvents.com. Slides related to materials discussed on the call will be available on both sites. A playback of the call will be available on both sites starting at 12 p.m. Eastern Time today. A playback of the call will also be available by telephone beginning at 12 p.m. Eastern Time today until 11:59 p.m. Eastern Time on June 21, 2014. The playback number is 1-855-859-2056 from within the U.S. and Canada or 1-404-537-3406 from outside the U.S. and Canada with the eight-digit reservation number 55899846.

 

Rite Aid is one of the nation’s leading drugstore chains with 4,581 stores in 31 states and the District of Columbia. Information about Rite Aid, including corporate background and press releases, is available through Rite Aid’s website at www.riteaid.com.

 

Statements, including guidance, in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “should,” and “will” and variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, but not limited to, our high level of indebtedness and our ability to make interest and principal payments on our debt and satisfy the other covenants contained in our debt agreements, general economic, market and competitive conditions, our ability to improve the operating performance of our stores in accordance with our long term strategy, the impact of private and public third-party payers continued reduction in prescription drug reimbursements and efforts to encourage mail order, our ability to manage expenses and our investments in working capital, outcomes of legal and regulatory matters and changes in legislation or regulations, including healthcare reform. These and other risks, assumptions and uncertainties are described in Item 1A (Risk Factors) of our most recent Annual Report on Form 10-K and in other documents that we file or furnish with the Securities and Exchange Commission, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Rite Aid expressly disclaims any current intention to update publicly any forward-looking statement after the distribution of this release, whether as a result of new information, future events, changes in assumptions or otherwise.

 

See the attached table for a reconciliation of a non-GAAP financial measure, Adjusted EBITDA to net income, the most comparable GAAP financial measure. We define Adjusted EBITDA as net income excluding the impact of income taxes (and any corresponding adjustments to tax indemnification asset), interest expense, depreciation and amortization, LIFO adjustments, charges or credits for facility closing and impairment, inventory write-downs related to store closings, debt retirements and other items (including stock-based compensation expense, sale of assets and investments and revenue deferrals related to our customer loyalty program).

 

###

 
 
 
 

 
 
RITE AID CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)
(unaudited)

   
May 31, 2014
 
March 1, 2014
ASSETS
           
Current assets:
           
Cash and cash equivalents
  $ 166,003     $ 146,406  
Accounts receivable, net
    910,624       949,062  
Inventories, net of LIFO reserve of $1,020,126 and $1,018,581
    2,933,316       2,993,948  
Prepaid expenses and other current assets
    188,593       195,709  
Total current assets
    4,198,536       4,285,125  
Property, plant and equipment, net
    1,974,204       1,957,329  
Goodwill
    83,971       -  
Other intangibles, net
    420,507       431,227  
Other assets
    269,299       271,190  
Total assets
  $ 6,946,517     $ 6,944,871  
                 
LIABILITIES AND STOCKHOLDERS' DEFICIT
               
Current liabilities:
               
Current maturities of long-term debt and lease financing obligations
  $ 112,818     $ 49,174  
Accounts payable
    1,364,271       1,292,419  
Accrued salaries, wages and other current liabilities
    1,078,442       1,165,859  
Total current liabilities
    2,555,531       2,507,452  
Long-term debt, less current maturities
    5,519,580       5,632,798  
Lease financing obligations, less current maturities
    71,988       75,171  
Other noncurrent liabilities
    845,772       843,152  
Total liabilities
    8,992,871       9,058,573  
                 
Commitments and contingencies
    -       -  
Stockholders' deficit:
               
Common stock
    978,038       971,331  
Additional paid-in capital
    4,486,685       4,468,149  
Accumulated deficit
    (7,474,402 )     (7,515,848 )
Accumulated other comprehensive loss
    (36,675 )     (37,334 )
Total stockholders' deficit
    (2,046,354 )     (2,113,702 )
Total liabilities and stockholders' deficit
  $ 6,946,517     $ 6,944,871  
 
 
 

 

RITE AID CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars in thousands, except per share amounts)
(unaudited)

   
Thirteen weeks ended May 31, 2014
 
Thirteen weeks ended June 1, 2013
Revenues
  $ 6,465,531     $ 6,293,057  
Costs and expenses:
               
Cost of goods sold
    4,662,552       4,472,066  
Selling, general and administrative expenses
    1,644,354       1,609,261  
Lease termination and impairment charges
    4,848       10,972  
Interest expense
    100,820       113,064  
Gain on sale of assets, net
    (370 )     (5,180 )
                 
      6,412,204       6,200,183  
                 
Income before income taxes
    53,327       92,874  
Income tax expense
    11,881       3,212  
Net income
  $ 41,446     $ 89,662  
                 
Basic and diluted earnings per share:
               
                 
Numerator for earnings per share:
               
Net income
  $ 41,446     $ 89,662  
Accretion of redeemable preferred stock
    -       (25 )
Cumulative preferred stock dividends
    -       (2,732 )
Income attributable to common stockholders - basic
    41,446       86,905  
Add back - Interest on convertible notes
    -       1,364  
Add back - Cumulative preferred stock dividends
    -       2,732  
Income attributable to common stockholders - diluted
  $ 41,446     $ 91,001  
                 
                 
                 
Denominator:
               
Basic weighted average shares
    963,332       893,871  
Outstanding options and restricted shares, net
    33,222       38,812  
Convertible preferred stock
    -       33,605  
Convertible notes
    -       24,800  
                 
Diluted weighted average shares
    996,554       991,088  
                 
Basic income per share
  $ 0.04     $ 0.10  
Diluted income per share
  $ 0.04     $ 0.09  
 
 
 

 

RITE AID CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
(unaudited)

   
Thirteen weeks ended May 31, 2014
 
Thirteen weeks ended June 1, 2013
Net income
  $ 41,446     $ 89,662  
Other comprehensive income:
               
Defined benefit pension plans:
               
Amortization of prior service cost, net transition obligation and net actuarial losses included in net periodic pension cost
    659       1,263  
Total other comprehensive income
    659       1,263  
Comprehensive income
  $ 42,105     $ 90,925  



 
 

 

RITE AID CORPORATION AND SUBSIDIARIES

SUPPLEMENTAL OPERATING AND CASH FLOW  INFORMATION
(Dollars in thousands, except per share amounts)
(unaudited)

   
Thirteen weeks ended May 31, 2014
 
Thirteen weeks ended June 1, 2013
             
SUPPLEMENTAL OPERATING INFORMATION
           
             
Revenues
  $ 6,465,531     $ 6,293,057  
Cost of goods sold
    4,662,552       4,472,066  
Gross profit
    1,802,979       1,820,991  
LIFO charge
    1,545       12,000  
FIFO gross profit
    1,804,524       1,832,991  
                 
Gross profit as a percentage of revenues
    27.89 %     28.94 %
LIFO charge as a percentage of revenues
    0.02 %     0.19 %
FIFO gross profit as a percentage of revenues
    27.91 %     29.13 %
                 
Selling, general and administrative expenses
    1,644,354       1,609,261  
Selling, general and administrative expenses as a percentage of revenues
    25.43 %     25.57 %
                 
Cash interest expense
    96,435       108,548  
Non-cash interest expense
    4,385       4,516  
Total interest expense
    100,820       113,064  
                 
                 
Adjusted EBITDA
    282,613       344,778  
Adjusted EBITDA as a percentage of revenues
    4.37 %     5.48 %
                 
Net income
    41,446       89,662  
Net income as a percentage of revenues
    0.64 %     1.42 %
                 
Total debt
    5,704,386       5,911,665  
Invested cash
    1,990       1,289  
Total debt net of invested cash
    5,702,396       5,910,376  
                 
                 
SUPPLEMENTAL CASH FLOW INFORMATION
               
                 
Payments for property, plant and equipment
    94,342       80,906  
Intangible assets acquired
    19,586       11,786  
Total cash capital expenditures
    113,928       92,692  
Equipment financed under capital leases
    1,683       5,373  
Gross capital expenditures
  $ 115,611     $ 98,065  
 
 
 

 

RITE AID CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL INFORMATION
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA
(In thousands)

   
Thirteen weeks ended May 31, 2014
 
Thirteen weeks ended June 1, 2013
             
             
Reconciliation of net income to adjusted EBITDA:
           
Net income
  $ 41,446     $ 89,662  
Adjustments:
               
Interest expense
    100,820       113,064  
Income tax expense
    11,881       3,212  
Depreciation and amortization
    103,105       101,246  
LIFO charge
    1,545       12,000  
Lease termination and impairment charges
    4,848       10,972  
Other
    18,968       14,622  
Adjusted EBITDA
  $ 282,613     $ 344,778  
Percent of revenues
    4.37 %     5.48 %
 

 
 

 

RITE AID CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in thousands)
(unaudited)

 
   
Thirteen weeks ended May 31, 2014
   
Thirteen weeks ended June 1, 2013
 
             
             
OPERATING ACTIVITIES:
           
Net income
  $ 41,446     $ 89,662  
Adjustments to reconcile to net cash provided by operating activities:
               
   Depreciation and amortization
    103,105       101,246  
   Lease termination and impairment charges
    4,848       10,972  
   LIFO charge
    1,545       12,000  
   Gain on sale of assets, net
    (370 )     (5,180 )
   Stock-based compensation expense
    4,156       4,240  
   Excess tax benefit on stock options
    (10,522 )     -  
   Changes in operating assets and liabilities:
               
   Accounts receivable
    41,347       47,797  
   Inventories
    59,375       6,935  
   Accounts payable
    86,324       (15,547 )
   Other assets and liabilities, net
    (91,506 )     (67,678 )
   Net cash provided by operating activities
    239,748       184,447  
INVESTING ACTIVITIES:
               
   Payments for property, plant and equipment
    (94,342 )     (80,906 )
   Intangible assets acquired
    (19,586 )     (11,786 )
   Acquisition of Health Dialog and RediClinic, net of cash acquired
    (65,306 )     -  
   Proceeds from sale-leaseback transactions
    -       3,989  
   Proceeds from dispositions of assets and investments
    1,873       6,610  
   Net cash used in investing activities
    (177,361 )     (82,093 )
FINANCING ACTIVITIES:
               
   Proceeds from issuance of long-term debt
    1,152,293       -  
   Net payments to revolver
    (49,000 )     (123,000 )
   Principal payments on long-term debt
    (1,157,443 )     (4,378 )
   Change in zero balance cash accounts
    (8,578 )     (867 )
   Net proceeds from the issuance of common stock
    10,904       6,744  
   Excess tax benefit on stock options
    10,522       -  
   Deferred financing costs paid
    (1,488 )     (1,403 )
   Net cash used in financing activities
    (42,790 )     (122,904 )
Increase (decrease) in cash and cash equivalents
    19,597       (20,550 )
Cash and cash equivalents, beginning of period
    146,406       129,452  
Cash and cash equivalents, end of period
  $ 166,003     $ 108,902  
 
 
 

 
 
RITE AID CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL INFORMATION
RECONCILIATION OF NET INCOME GUIDANCE TO ADJUSTED EBITDA GUIDANCE
YEAR ENDING FEBRUARY 28, 2015
(In thousands, except per share amounts)

   
Guidance Range
   
Low
 
High
             
Sales
  $ 26,000,000     $ 26,500,000  
                 
Same store sales
    2.50 %     4.50 %
                 
Gross capital expenditures
  $ 525,000     $ 525,000  
                 
Reconciliation of net income to adjusted EBITDA:
               
Net income
  $ 298,000     $ 408,000  
Adjustments:
               
Interest expense
    390,000       390,000  
Income tax expense
    70,000       60,000  
Depreciation and amortization
    411,000       409,000  
LIFO charge
    15,000       -  
Store closing and impairment charges
    55,000       50,000  
Loss on debt retirement
    17,000       17,000  
Other
    19,000       16,000  
Adjusted EBITDA
  $ 1,275,000     $ 1,350,000  
                 
                 
Diluted income per share
  $ 0.30     $ 0.40